FIELD: medicine. SUBSTANCE: the suggested vaccine contains immunogen of caprine arthritis-encephalitis virus (CAEV) and pharmaceutically acceptable carrier. The innovation suggests, also, the method to stimulate patient's immune reaction to human immunodeficiency virus-1 (HIV-1) infection or CAEV- infection due to introduction of therapeutically efficient amount of CAEV immunogen for a patient. The innovation suggests the method to stimulate immune reaction in vitro due to the contact of a lymphocyte with therapeutically efficient amount of CAEV immunogen, and includes the methods to predict nucleotide sequence at a divergence against a standard CAEV-Co. EFFECT: higher immune protection. 24 cl, 5 dwg, 3 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
T-CELLULAR VACCINE FOR CEREBROSPINAL SCLEROSIS TREATMENT | 1998 |
|
RU2209633C2 |
DESIGNATION AND APPLYING GENES ENCODING PATHOGENIC EPITOPES FOR TREATMENT OF AUTOIMMUNE DISEASE | 1997 |
|
RU2248807C2 |
COMPOSITIONS AND METHODS OF GENETIC MATERIAL DELIVERY | 1994 |
|
RU2174845C2 |
RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES | 1999 |
|
RU2270864C2 |
COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2478400C2 |
Authors
Dates
2002-12-20—Published
1997-03-14—Filed